We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Cold Plasma Could Treat Nail Infections Caused by Fungi

By HospiMedica International staff writers
Posted on 03 Nov 2016
A new study will test cold atmospheric ionized plasma gas as a new option for treating onychomycosis, the most common fungal nail infection.

Researchers at the University of Southampton (United Kingdom) and Solent NHS Trust (Winchester, United Kingdom) are planning a study to investigate the use of plasma gas to treat onychomycosis in just one or two treatments. More...
The tissue-tolerant ionized plasma gas device will operate at low temperatures that do not damage normal tissue. The plasma device is being developed together with industrial gas producer Linde (Munich, Germany).

The medical device will be tested in 80 patients who have onychomycosis in both large toenails. One large toenail will be surface-treated by a podiatrist during a short visit at the study site, and the other will remain untreated. Subjects will be reviewed at 1, 3, 6, 9, and 12 months after treatment, and will be assessed for clearance of the fungal infection and evidence of clear nail growth. The study will be undertaken at a single site in the Southampton (United Kingdom) area.

“Fungal nail infections might be seen as a purely cosmetic problem, but in people with diabetes, it can lead to very serious infections which are difficult to treat,” said lead researcher David Voegeli, PhD, BSc, RN, of the University of Southampton department of health sciences. “We believe this new way of treating patients will be more effective in getting to the infection quickly, possibly reducing the need for antibiotics in the future.”

“We are facing huge challenges in antimicrobial resistance and we desperately need to find new ways of treating conditions before they need antibiotics,” said Professor Tim Leighton, MD, chair of the University of Southampton's network for antimicrobial resistance and infection prevention (NAMRIP). “This is an exciting study which has great potential in treating a common condition early, before antibiotic interventions are needed.”

Onychomycosis is the most common disease of nails, and constitutes about half of all nail abnormalities; it is prevalent in up to 10% of the population. Dermatophytes are the fungi most commonly responsible for onychomycosis in the temperate western countries, while Candida and nondermatophytic molds are more frequently involved in the tropics, and in subtropic areas with a hot, humid climate. Most current treatments involve topical or oral antifungal medication that requires months of administration, and is not very effective.

Related Links:
University of Southampton
Solent NHS Trust
Linde

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
LED Surgical Lamp
ACEMST35/57
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.